[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2837707B1 - Utilisation de la 8'-hydroxydihydroergotamine pour un medicament anxiolytique - Google Patents

Utilisation de la 8'-hydroxydihydroergotamine pour un medicament anxiolytique

Info

Publication number
FR2837707B1
FR2837707B1 FR0204080A FR0204080A FR2837707B1 FR 2837707 B1 FR2837707 B1 FR 2837707B1 FR 0204080 A FR0204080 A FR 0204080A FR 0204080 A FR0204080 A FR 0204080A FR 2837707 B1 FR2837707 B1 FR 2837707B1
Authority
FR
France
Prior art keywords
hydroxydihydroergotamine
anxiolytic drug
anxiolytic
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR0204080A
Other languages
English (en)
Other versions
FR2837707A1 (fr
Inventor
Louis Guesnier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SCHWARZ PHARMA LAB
Original Assignee
SCHWARZ PHARMA LAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SCHWARZ PHARMA LAB filed Critical SCHWARZ PHARMA LAB
Priority to FR0204080A priority Critical patent/FR2837707B1/fr
Publication of FR2837707A1 publication Critical patent/FR2837707A1/fr
Application granted granted Critical
Publication of FR2837707B1 publication Critical patent/FR2837707B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR0204080A 2002-04-02 2002-04-02 Utilisation de la 8'-hydroxydihydroergotamine pour un medicament anxiolytique Expired - Lifetime FR2837707B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0204080A FR2837707B1 (fr) 2002-04-02 2002-04-02 Utilisation de la 8'-hydroxydihydroergotamine pour un medicament anxiolytique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0204080A FR2837707B1 (fr) 2002-04-02 2002-04-02 Utilisation de la 8'-hydroxydihydroergotamine pour un medicament anxiolytique

Publications (2)

Publication Number Publication Date
FR2837707A1 FR2837707A1 (fr) 2003-10-03
FR2837707B1 true FR2837707B1 (fr) 2005-02-04

Family

ID=27839385

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0204080A Expired - Lifetime FR2837707B1 (fr) 2002-04-02 2002-04-02 Utilisation de la 8'-hydroxydihydroergotamine pour un medicament anxiolytique

Country Status (1)

Country Link
FR (1) FR2837707B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1616192A1 (fr) * 2002-12-23 2006-01-18 Bayer HealthCare AG Diagnostic et traitement de maladies associees au recepteur 2b (5-hteb) de 5-hydroxytryptamine (serotonine)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE605937A (fr) * 1960-07-12 1962-01-10 Sandoz Sa Nouveaux hydrazides lysergiques et leur préparation
IL39948A (en) * 1972-07-19 1973-05-31 Pharmaplantex Ltd Pharmaceutical compositions containing a 1,4-benzodiazepine derivative and another pharmaceutically acceptable compound

Also Published As

Publication number Publication date
FR2837707A1 (fr) 2003-10-03

Similar Documents

Publication Publication Date Title
FR16C1012I2 (fr) Utilisation therapeutique d'anticorps anti-cs1
PL375571A1 (en) Squeeze-bottle of liquid medicine
NO20044054L (no) Administrering av midler for behandling av betennelse
NO20041315L (no) Medikamentavleveringssystem
NO20053150D0 (no) System for administrasjon av medisin.
AU2003247725A8 (en) Interferometer system of compact configuration
FR2867778B1 (fr) Utilisation de derives d'indazolecarboxamides pour la preparation d'un medicament destine au traitement et a la prevention du paludisme
DE60301989D1 (de) Medizinisches Ultraschallsystem
AU2003243439A8 (en) Medical device for intra-lumenal delivery of pharmaceutical agents
DE50209245D1 (de) Neuroprotektives medikament
DE60203537D1 (de) 5ht1-rezeptoragonist enthaltendes arzneimittel
IS6172A (is) Notkun melatoníns til lækninga
DE60234766D1 (de) Ringverwaltungssystem
FR2820311B3 (fr) Distributeur de medicament portatif
FR2837707B1 (fr) Utilisation de la 8'-hydroxydihydroergotamine pour un medicament anxiolytique
FR2839453B1 (fr) Utilisation de novirhabdovirus modifies pour l'obtention de vaccins
MA27689A1 (fr) Forme galenique orale pour la liberation controlee de medicament
FR2858930B1 (fr) Unite mobile d'aspiration bronchique
ES1052302Y (es) Soporte de suministros medicos.
NO20001894D0 (no) Anvendelse av TNF-antagonister som medikamenter for behandling av septiske sykdommer
FR2843883B1 (fr) Extraits de sangsues pour psoriasis
PT1576951E (pt) Formulações para administração rectal de agentes com acção trombolitica
FR2843304B1 (fr) Extraits de sangsues pour stents
FR2851466B1 (fr) Utilisation cosmetique d'inositol.
FR2878160B1 (fr) Utilisation du n-acetyl-taurinate de magnesium pour la preparation de medicaments inhibiteurs de l'hypersensiblite photique

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20